BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7482735)

  • 1. The fate of renal allografts functioning for a minimum of 20 years (level 5A)--indefinite success or beginning of the end? A proposed classification of long-term allograft survivals.
    Braun WE; Popowniak KL; Nakamoto S; Gifford RW; Straffon RA
    Transplantation; 1995 Oct; 60(8):784-90. PubMed ID: 7482735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The UNOS renal transplant registry.
    Cecka JM
    Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of initial slow graft function on renal allograft rejection and survival.
    Humar A; Johnson EM; Payne WD; Wrenshall L; Sutherland DE; Najarian JS; Gillingham KJ; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):623-7. PubMed ID: 9408697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The UNOS Scientific Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Completely reversed acute rejection episodes do not influence the long-term renal allograft survival].
    Wu JY; Chen JH; Wang YM; Zhang JG; Zhu C; Wang SY; Zhang P; Huang HF; He Q
    Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(2):106-9. PubMed ID: 12812676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations.
    Emiroğlu R; Yagmurdur MC; Karakayali F; Haberal C; Ozcelik U; Colak T; Haberal M
    Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multi-factor analysis of kidney regraft outcomes.
    Gjertson DW
    Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
    Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of race and ethnicity on kidney allograft outcome.
    Katznelson S; Gjertson DW; Cecka JM
    Clin Transpl; 1995; ():379-94. PubMed ID: 8794281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preemptive kidney transplant from deceased donors: an advantage in relation to reduced waiting list.
    Pérez-Flores I; Sánchez-Fructuoso A; Calvo N; Marques M; Anaya S; Ridao N; Rodríguez A; Barrientos A
    Transplant Proc; 2007 Sep; 39(7):2123-4. PubMed ID: 17889112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant.
    Elmagd MM; Bakr MA; Metwally AH; Wahab AM
    Exp Clin Transplant; 2008 Mar; 6(1):42-7. PubMed ID: 18405244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of gender and age matching for long-term graft survival in living donor renal transplantation.
    Kwon OJ; Kwak JY; Kang CM
    Transplant Proc; 2005 Mar; 37(2):726-8. PubMed ID: 15848514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major effects of delayed graft function and cold ischaemia time on renal allograft survival.
    Quiroga I; McShane P; Koo DD; Gray D; Friend PJ; Fuggle S; Darby C
    Nephrol Dial Transplant; 2006 Jun; 21(6):1689-96. PubMed ID: 16490743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-transplant hypertension: a major risk factor for chronic progressive renal allograft dysfunction?
    Frei U; Schindler R; Wieters D; Grouven U; Brunkhorst R; Koch KM
    Nephrol Dial Transplant; 1995; 10(7):1206-11. PubMed ID: 7478125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A
    Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal allograft function and cardiovascular risk in recipients of kidney transplantation after successful pregnancy.
    Gutiérrez MJ; González P; Delgado I; Gutiérrez E; González E; Siqueira RC; Andrés A; Morales JM
    Transplant Proc; 2009; 41(6):2399-402. PubMed ID: 19715932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.